ACADIA Pharmaceuticals Inc (ACAD)
17.05
-0.03
(-0.18%)
USD |
NASDAQ |
May 03, 16:00
17.06
0.00 (0.00%)
After-Hours: 20:00
ACADIA Pharmaceuticals Stock Buybacks (Quarterly): -5.434M for Dec. 31, 2023
Stock Buybacks (Quarterly) Chart
Historical Stock Buybacks (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -5.434M |
| September 30, 2023 | -12.75M |
| June 30, 2023 | -5.478M |
| March 31, 2023 | -1.466M |
| December 31, 2022 | -1.614M |
| September 30, 2022 | -0.287M |
| June 30, 2022 | -3.831M |
| March 31, 2022 | -2.467M |
| December 31, 2021 | -4.365M |
| September 30, 2021 | -1.066M |
| June 30, 2021 | -5.005M |
| March 31, 2021 | -7.726M |
| December 31, 2020 | -18.13M |
| September 30, 2020 | -11.72M |
| June 30, 2020 | -47.40M |
| March 31, 2020 | -3.754M |
| December 31, 2019 | -43.06M |
| September 30, 2019 | -319.97M |
| June 30, 2019 | -4.646M |
| March 31, 2019 | -4.176M |
| December 31, 2018 | -300.60M |
| September 30, 2018 | -0.211M |
| June 30, 2018 | -2.953M |
| March 31, 2018 | -2.88M |
| December 31, 2017 | -4.791M |
| Date | Value |
|---|---|
| September 30, 2017 | -7.897M |
| June 30, 2017 | -7.01M |
| March 31, 2017 | -11.49M |
| December 31, 2016 | -3.39M |
| September 30, 2016 | -226.08M |
| June 30, 2016 | -6.438M |
| March 31, 2016 | -282.99M |
| December 31, 2015 | -9.377M |
| September 30, 2015 | -1.132M |
| June 30, 2015 | -2.599M |
| March 31, 2015 | -1.439M |
| December 31, 2014 | -2.807M |
| September 30, 2014 | -1.282M |
| June 30, 2014 | -1.72M |
| March 31, 2014 | -198.04M |
| December 31, 2013 | -0.629M |
| September 30, 2013 | -0.974M |
| June 30, 2013 | -109.87M |
| March 31, 2013 | -0.208M |
| December 31, 2012 | -91.24M |
| September 30, 2012 | -6.869M |
| June 30, 2012 | -0.067M |
| March 31, 2012 | -0.031M |
| December 31, 2011 | -0.106M |
| September 30, 2011 | -0.002M |
Stock Buyback Definition
Stock buybacks are when companies buy back their own stock, removing it from the marketplace. Stock buybacks increase the value of the remaining shares because there is now less common stock outstanding and company earnings are split among fewer shares.
Stock Buybacks (Quarterly) Range, Past 5 Years
-319.97M
Minimum
Sep 2019
-0.287M
Maximum
Sep 2022
-26.32M
Average
-5.005M
Median
Jun 2021
Stock Buybacks (Quarterly) Benchmarks
| Amylyx Pharmaceuticals Inc | 0.00 |
| Regulus Therapeutics Inc | 0.047M |
| Minerva Neurosciences Inc | -20.00M |
| Viking Therapeutics Inc | -597.12M |
| CytomX Therapeutics Inc | -- |